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Abstract: While fatigue is prevalent in chronic diseases, the neural mechanisms underlying this
symptom remain unknown. Magnetic resonance imaging (MRI) has the potential to enable us to
characterize this symptom. The aim of this review was to gather and appraise the current literature
on MRI studies of fatigue in chronic diseases. We systematically searched the following databases:
MedLine, PsycInfo, Embase and Scopus (inception to April 2016). We selected studies according to
a predefined inclusion and exclusion criteria. We assessed the quality of the studies and conducted
descriptive statistical analyses. We identified 26 studies of varying design and quality. Structural and
functional MRI, alongside diffusion tensor imaging (DTI) and functional connectivity (FC) studies,
identified significant brain indicators of fatigue. The most common regions were the frontal lobe,
parietal lobe, limbic system and basal ganglia. Longitudinal studies offered more precise and reliable
analysis. Brain structures found to be related to fatigue were highly heterogeneous, not only between
diseases, but also for different studies of the same disease. Given the different designs, methodologies
and variable results, we conclude that there are currently no well-defined brain indicators of fatigue
in chronic diseases.
Keywords: fatigue; magnetic resonance; chronic diseases
1. Introduction
The perception of fatigue is subjective, due to the interchangeable use of “tiredness” and the
clinically pertinent experience of fatigue. There is no general consensus on the definition of fatigue.
Nevertheless, for clinical purposes, it has been defined as an overwhelming feeling of physical and/or
mental tiredness, along with a lack of energy which constrains the daily activities of the patient [1].
As opposed to weakness related to primary muscle disorders, fatigue has been conceived as
a central nervous system event, considering that it remains after resting or sleeping. It may involve
lack of attention, decline of executive and cognitive functions, difficulties in information processing or
loss of productivity [2,3].
This symptom is often reported as one of the most burdensome, and the main cause of decrease
in quality of life within chronic diseases, such as Rheumatoid Arthritis (RA) [4,5], Systemic Lupus
Erythematosus (SLE) [6], primary biliary cirrhosis [7], or Human Immunodeficiency Virus (HIV) [8]
among others.
There is a growing body of research that reports that aetiology of cognitive fatigue is
multifactorial [9–11]. Whereas inflammation and disease activity have shown poor correlation with
fatigue [12–15], variables such as pain [13,14,16–21], disability [12,16,17,21–24] and depression [13,14,25–28]
among others appear to be commonly implicated in the complex process of this symptom. In summary,
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fatigue is a non-precise and greatly subjective symptom, difficult to specify, and therefore, arduous to
measure and study.
Due to its multidimensional nature, a substantial number of questionnaires to assess fatigue have
been developed [29,30]. These questionnaires may consist of a single-item measure, multi-item
measures that assess further fatigue issues and calculate an overall score, or multidimensional
measures with sub-scores for several domains of fatigue (e.g., mental, physical or emotional factors).
Notwithstanding the broad number of fatigue questionnaires, these are subjective measurement
tools. The absence of objective biological measures and the lack of understanding of the mechanisms
underlying fatigue, are the greatest obstacles in the development of therapies.
Kluger et al. [31] proposed the concept of fatigability as an objective measure of fatigue, to be
distinguished from subjective fatigue, assessed through self-rated measures. This objective fatigue
may be, for example, the one related to neural activity. a way to assess fatigability is to subject the
patient to sustained cognitive tasks [32,33].
Structural Magnetic Resonance Imaging (sMRI) is an accurate identifier of macroscopic diseases,
but is limited in its ability to identify microscopic structural alterations in the brain, which are thought
to be the most relevant to fatigue [34,35]. Nevertheless, other sophisticated MRI techniques can
address this gap. In particular, Diffusion Tensor Imaging (DTI) has already reported some possible
neural indicators of fatigue in chronic disorders such as Multiple Sclerosis (MS) [34] and Fibromyalgia
(FM) [35] among others.
Another promising technique in the search for the brain structures involved in fatigue is functional
Magnetic Resonance Imaging (fMRI). Here, the performance of cognitive tasks during fMRI has
demonstrated several differences between fatigue and non-fatigue populations [36–38]. Furthermore,
great promise in improving the usefulness of fMRI has been shown in the study of brain activity in the
resting state [39,40].
Taken together, these MRI techniques provide a tool of inestimable value in the study of the brain
mechanisms involved in fatigue, with its consequent potential as an objective biomarker. In spite of
this fact, few studies have employed these techniques in the field of chronic diseases. Additionally,
the diversity of study designs, interventions, techniques and analytical analysis makes it difficult
to compare neural correlates of fatigue and hence, to confirm if the neurophysiology of fatigue is
something generic or specific for each disease.
This systematic review (SR) aims to summarize those MRI studies applied in the search of neural
indicators of fatigue in chronic diseases. Our main goals are: (1) to determine if there are well-defined
neural indicators of fatigue in chronic diseases; (2) to determine if there are common fatigue indicators
across chronic diseases; and given the variety of interventions and designs; (3) to determine which is
the best approach to follow in the search of neural indicators of fatigue.
2. Methods
To ensure high quality reporting, the current systematic review adheres to the recommendation
for systematic reviews of the PRISMA statement [41]. The literature search was based on a predefined
list of search terms, inclusion, exclusion and quality criteria. The approaches used for data collection,
extraction of characteristics and analysis of results are fully described.
2.1. Information Sources
A comprehensive search strategy was developed for studying fatigue within chronic diseases
through neuroimaging techniques. Experimental and observational studies, with prospective or
retrospective data collection, cross-sectional and longitudinal design, cohort-, case control- and
randomized-designed studies were included in this review.
The review was carried out by searching electronic databases and through consultation with experts
in the field and a medical librarian specialist. Studies were identified through Medline (Ovid Medline (R)
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1946 to 22 April 2016), Embase (1974 to 27 April 2016), PsycInfo (1806 to 22 April 2016) and Scopus. All
studies were included, without any language or date restriction. The last search was run on 28 April 2016.
2.2. Search
The following search terms were used for all databases: (fatigue OR lethargy OR weakness
OR weariness OR debility OR enervation OR exhaustion OR faintness OR feebleness OR heaviness
OR languor OR lassitude OR listlessness OR burnout OR fatigation OR tiredness OR overtired* OR
asthenia) [title] AND (“magnetic resonance” OR MRI OR fMRI OR neuroimaging OR “diffusion tensor
imaging” OR “voxel-based morphometry” OR “voxel based morphometry”) [title/abstract] AND
(brain OR cerebr* OR neur*) [title/abstract] NOT (“multiple sclerosis” OR MS) [title].
2.3. Study Selection
In the search of neural changes related to fatigue, the SR was focused on the study of mental or
cognitive fatigue, discarding physical fatigue due to muscular disorders. The non-invasive and non-ionizing
nature, high resolution, great contrast between tissues and ability to detect subtle changes, makes the MRI
one of the favourite tools in current clinical and research practice [42]. This SR focuses on MRI studies,
excluding other neuroimaging techniques such as Computed Tomography (CT) or Positron Emission
Tomography (PET). Another fact to take into account is that primary central nervous system (CNS) diseases
generally induce gross structural abnormalities on MRI. Such abnormalities may mask some of the more
subtle neural correlates (measured by more advanced MR protocols), which are expected to provide insight
in the context of fatigue. Therefore, CNS diseases such as Parkinson’s disease, post-stroke syndrome,
multiple sclerosis or amyotrophic lateral sclerosis among others were excluded.
As opposed to epidemiological studies, most of the neuroimaging studies make use of small
sample sizes. However, good statistical power can still be achieved with sample sizes between
10–15 subjects [43,44]. In this review, studies with a minimum of 10 subjects were included.
Therefore, studies were included if they met the following criteria: (1) observational or interventional
study design; (2) investigation of mental or cognitive fatigue; (3) application of structural or functional
magnetic resonance imaging and (4) study of chronic disease. Studies were excluded if they: (1)
study muscular or physical fatigue; (2) use non MR techniques (i.e., Positron Emission Tomography
(PET), Computed Tomography (CT), etc.); (3) study primary CNS diseases (as Multiple Sclerosis (MS),
Amyotrophic Lateral Sclerosis (ALS), stroke, etc.); (4) had sample sizes with less than 10 participants and
(5) were single cases. After deletion of duplicates, the titles and abstracts of all records were reviewed.
2.4. Data Extraction
The specific outcomes extracted from each study included: (1) disease; (2) demographic
characteristics of patients (number, male/female, age mean and standard deviation); (3) demographic
characteristics of control group (number, male/female, age mean and standard deviation); (4) study
design (cross-sectional or longitudinal); (5) period of follow-up (if applicable); (6) task during fMRI
(if applicable); (7) method of assessment of fatigue; (8) imaging modality and (9) statistical approach.
2.5. Synthesis of Results
Brain correlates of fatigue were extracted for each of the studies. The outcomes were analysed
according to: (1) illness and (2) neuroimaging techniques. Fatigue inducing tasks were reported for
functional neuroimaging studies.
2.6. Quality Assessment
Those studies accomplishing the inclusion and exclusion criteria were evaluated for quality assessment
using an established 10-item quality score [45]. The list of questions are: (1) Does the study have a clearly
defined research objective? (2) Does the study adequately describe the inclusion criteria? (3) Does
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the study adequately describe the exclusion criteria? (4) Does the study report on the population
parameters/demographics? (5) Does the study report details on assessment of fatigue? (6) Does the
study provide details of imaging protocol? (7) Does the study provide a proper control group? (8) Does the
study apply proper statistical analysis? Correction for multiple comparisons? (9) Does the study adequately
report on the strength of the results? and (10) Do the authors report on the limitations of their study?
3. Results
3.1. Study Selection
The search of Medline, Embase, PsycInfo and Scopus databases provided a total of 1202 citations.
After deleting duplicates, 727 papers remained. Of these, a total of 655 studies were discarded after
reviewing titles and abstract, as they did not meet the inclusion or exclusion criteria. Two hundred
and forty-seven were discarded for reporting single cases. Ninety-five of the studies were reviews,
book chapters, did not have an abstract or were theoretical reports. a further 169 studies were
excluded for being focused on muscular or physical fatigue. From the remaining papers, 38 more
were discarded, as they studied fatigue in healthy participants only, and another 59 studies because
they investigated non related illnesses (brain cancer, ALS, MS, infarction, stroke, clinically isolated
syndrome, stress-related exhaustion, cocaine addiction or scleroderma). Twenty-two more studies
were excluded for not studying fatigue, 7 for not using neuroimaging techniques, 17 more for using
non related imaging techniques (PET, CT, etc.), and 1 because it focused on animal models. Finally, 72
remaining papers which met the inclusion and exclusion criteria were selected for full-text reading.
After reading the full papers, 46 studies were discarded. From them, 29 were meeting abstracts or
posters or it was not possible to access the full text [46–74]. Another 6 of the papers used a very small
number of patients [36,75–79], 6 of them did not fully define fatigue [80–85], 1 was a protocol [86],
1 a mini review [87], 2 of them employed non related imaging techniques [88,89] and another one
studied physical fatigue [90].
Finally, 26 studies remained [39,40,91–114]. Figure 1 shows the process followed in this review.
Figure 1. Flowchart of the review procedure.
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3.2. Study Details and Characteristics
Table 1 summarizes the study characteristics pertinent to our research: demographic features,
study design, duration of follow-up, task during the fMRI, fatigue assessment, imaging modality and
statistic methods.
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Table 1. Characteristics of included studies.
Ref. Disease
User Group Control Group
Design Follow-Up Task FatigueAssessment
Modality Statistical Method
n Male/Female
Age Mean
(std) n
Male/
Female
Age Mean
(std)
[93] AS
129 TNF-treated 95/34 43.6 (11.4) NA NA NA Cross-sectional NA NA FSS NA Pearson test, Student t test, paired t test,
Wilcoxon signed-rank test, Spearman’s
rank order correlation, forward stepwise
selection in multivariate GLM14 11/3 37.6 (11.9) 14 11/3 37.2 (10.2) Longitu-dinal
At baseline and 4 months
after the start of TNF
treatment
NA FSS sMRI
[97] AS 20 15/5 34.8 (11.9) 20 15/5 34.9 (9.6) Cross-sectional NA NA FSS sMRI, DTI
MonteCarlo simulations, Spearman’s
correlation, multiple stepwise regression
analysis
[98] Cancer
32 and 33 BC
scheduled and not
indicated to
receive ChT
0/32
0/33
50.2 (9.2)
(Pre-ChT+)
52.4 (7.3)
(Pre-ChT-)
38 0/38 50.1 (8.7) Cross-sectional NA
ToL,
Paired
Associates
Memory
Task
CFS
sMRI, FLAIR,
1H-MRS,
PRESS, DTI,
fMRI
ANOVA, Chi-squared test, z-scores,
Mahalanobis Distance, logistic regression,
variance-covariance matrix
[99] Cancer
28 and 37 treated
with and without
ChT
0/28
0/37
50.0 (10)
(ChT)
53.0 (9) (No
ChT)
32 0/32 50.0 (9) Longitu-dinal 1 month post-ChT (aprox. 5months between scans) VWMT FACIT-F fMRI
Multiple linear regression analysis, t tests,
ANOVA, Pearson correlation
[100] Cancer
20 fatigued cancer
survivors 10/10 47.9 (10.1)
20 non fatigue
cancer survivors 10/10 48.9 (9.7) Cross-sectional NA NA
CIS-fatigue
NA Shapiro-Wilk test, Chi square tests,
independent samples t tests,
Mann-Whitney U tests, Wilcoxon
matched-pairs tests25 fatigued cancer
survivors (selected
for intervention)
14/11 48.8 (9.4)
14 fatigued
cancer survivors
(selected for
waiting list)
5/9 50.6 (10.9) Longitu-dinal At baseline and 6 monthslater
CBT (for
the user
group)
sMRI, 1H-MRS
[101] PBC
14 PBC (stage I–II
disease) 4 PBC
(stage III–IV)
0/14 0/4
60.0 (–)
(41–76) a
48.0 (–)
(39–59) a
11 HC 0/11 47 (–) (38–65) a Cross-sectional NA NA FIS sMRI, 1H-MRS, MTR
Shapiro-Wilk test, Student’s t test,
Mann-Whitney U test, Pearson’s
correlation
[96] GPA 12 fatigued 16 nonfatigued 6/6 6/8
58.5 (15.9)
(fatigued)
51.6 (13.8)
(non
fatigued)
13 general
popula-tion with
idio-pathic
fatigue
7/6 52.2 (10.5) Cross-sectional NA PASAT CFS sMRI, fMRI Fisher’s exact tests, t tests, Mann-Whitneytests, MonteCarlo simulations
[102] GPA 14 GPA withchronic fatigue 6/8 58.6 (15.1)
14 GPA without
fatigue 6/8 51.6 (13.8) Cross-sectional NA NA CFS
sMRI, DTI,
FLAIR Mann-Whitney tests, t tests, x
2 tests
[103] Gulf WarIllness 31 11/9
45.9 (–)
(43.2–48.4) a 20 25.6
45.6 (–)
(41.2–50.5) a Cross-sectional NA NA
Ordinal
fatigue
rating, CFS,
MFI, SF-36
DTI
Student’s t test, Fisher’s exact tests, p
values, Bonferroni corrections, ROC,
Pearson’s function, Spearman’s function,
stepwise multivariate linear regression
analysis
[104] Hepatitis C
23 initiation IFN-α
treatment (19
completed both
MRI scans, and 20
both blood
samples)
17/6 48.8 (10.9) NA NA NA Longitu-dinal
qMT and blood sampling at
baseline and 4 h after IFN-α
injection. Behavioural and
psychological assessments
at both scanning sessions
and at treatment weeks 4, 8,
12 and 24
NA VAS-f sMRI, qMT
ANOVA, paired sample t-tests, regression
analysis, Mauchly’s sphericity test,
Levenberg-Marquardt nonlinear least
squares, FEW
Diagnostics 2018, 8, 42 7 of 24
Table 1. Cont.
Ref. Disease
User Group Control Group
Design Follow-Up Task FatigueAssessment
Modality Statistical Method
n Male/Female
Age Mean
(std) n
Male/
Female
Age Mean
(std)
[105] HIV 82 fatigued HIVpatients 71/11
44.0
(41–50) b
46 non- fatigued
HIV patients 41/5 48.0 (43–54)
b Longitu-dinal
At baseline, and weeks 12
and 24 (Just 62 of the 128
patients underwent
1H-MRS)
NA FSS MRS Kuskal-Wallis tests, Score tests, GEEmodels
[95] PPS 42 PPS 49 MS
15/27
(PPS)
17/32
(MS)
60.86 (7.65)
(PPS)
46.18 (9.4)
(MS)
27 11/16 46.96 (14.58) Cross-sectional NA NA FSS sMRI Multivariate linear regression, Spearmancorrelation, unpaired t-test
[92] PPS 22 – – NA NA NA Cross-sectional NA NA
Postpolio
fatigue
questionnaire
sMRI Produce moment correlations, linearregression, independent t tests
[39] CFS 17 ME/CFS 0/17 49.82 (11.78) 17 HC 0/17 48.88 (12) Cross-sectional NA NA FFQ, VAS sMRI, pCASLFC Spearman’s rho
[40] CFS 19 ME/CFS 0/19 52.33 (10.63) 17 HC 0/17 48.75 (11.75) Cross-sectional NA NA MFI sMRI, ASL FC,BOLD FC t-tests, ICA, Pearson
[106] CFS 18 0/18 43.9 (4.8) 18 HC 0/18 45.9 (3.2) Cross-sectional NA
6 min
passive-
viewing
block
scan
CFS sMRI, fMRI,FC Fisher, independent t-tests, ANOVA
[107] CFS 15 7/8 46.5 (13.2) 14 6/8 46.6 (14.6) Cross-sectional NA NA MFI-20 sMRI, DTI,ASL Pearson correlation, t tests, ROC curve
[108] CFS 18 2/16 44.2 (11.1) 41 HC 8/33 47.2 (9.2) Cross-sectional NA Gambling MFI-20,SF-36 sMRI, fMRI
t-test, Chi-square test, Fisher exact test,
Welch t-test, MANCOVA, Bravais-Pearson
correlation
[109] CFS 25 6/19 31.7 (8.8) 25 HC 6/19 33.7 (10.3) Cross-sectional NA NA
CFS
fatigue
duration
sMRI Regressions, Bonferroni corrected p values
[110] CFS 12 4/8 33.75 (7.64) 11 HC 4/7 34.36 (6.77) Cross-sectional NA
Fatigue
and
anxiety
provocation
task
CFS,
PF-SF36 sMRI, fMRI Student’s t tests, x
2, ANOVA
[91] CFS 22 0/22 36.6 (2.5) 22 HC 0/22 37.1 (2.2) Longitu-dinal Before and after CBT (6–9months) NA
Physical
assessment
(actometer),
perceived
fatigue
severity
(checklist
individual
strength)
sMRI
Tailed multivariate linear regression
analysis, t-tests, family-wise error
correction, Spearman’s correlation,
Mahalanobis distance to check for
multivariate outliers
[111] CFS 17 7/10 35.53 (6.17) 12 HC 4/8 33.5 (7.12) Cross-sectional NA n-Backtask
PF-SF36,
CFS sMRI, fMRI
Student t test, x2, Mann-Whitney U tests,
Wilcoxon test
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Table 1. Cont.
Ref. Disease
User Group Control Group
Design Follow-Up Task FatigueAssessment
Modality Statistical Method
n Male/Female
Age Mean
(std) n
Male/
Female
Age Mean
(std)
[112] CFS
6 CFS with verbal
working memory
difficulties
according to
PASAT
0/6 38.17 (9) 7 3/4 30.71 (9.6) Cross-sectional (scan) Baseline → task1 →task2 → task1 → task2
Auditory
monitoring
test,
Neuropsychological
testing sMRI, Student t test, analysis of covariance
19 CFS without
verbal memory
difficulties
3/16 37.53 (8) 15 5/10 30.80 (7.5) Cross-sectional
(scan) Baseline → task1 →
task2 → task1 → task2
(STAI) before and after
scanner
mPASAT,
BDI,
STAI
Neropsychological
testing
MFI-20
fMRI
[94] CFS 16 10/6 34.0 (-) 49 HC 27/22 34.44 (–) Cross-sectional NA NA
Self-reported
ratings
based on
daily
activities
sMRI Permutation tests, Spearman’s rankcorrelation coefficient
[113] CFS 16 0/16 28.4 (6) 16 HC 0/16 24.9 (6.4) Cross-sectional NA
Motor
and
visual
imagery
task
CIS-R,
mean
actometer
score
sMRI, fMRI GLM, regressions MANOVA, ANCOVA
[114] CFS
15 without
depression 11
with depression
7/8 1/10
28.4 (–)
(25.5–31.3) a
31.3 (–)
(27.7–34.8) a
18 HC 3/15 32.9 (–)(29.3–36.5) a Longitu-dinal
Cognitive testing at
baseline and 3–6 months
later (just for 14 subjects)
NA fatiguequestionnaire sMRI
ANOVA, multiple linear regression
analysis
ANOVA: Analysis of Variance; AS: Ankylosing Spondylitis; ASL: Arterial Spin Labelling; BC: breast cancer; BOLD: Blood Oxygen Level Dependent; CBT: Cognitive Behaviour Therapy;
CFS: Chronic Fatigue Syndrome or Chalder Fatigue Scale; ChT: chemotherapy; CIS: Checklist Individual Strength; DTI: Diffusion Tensor Imaging; FACIT-F: Functional Assessment of
Chronic Illness Therapy—fatigue; FC: functional connectivity; FEW: Family Wise Error; FFQ: Florida Fatigue Questionnaire; FIS: Fatigue Impact Scale; FLAIR: Fluid-attenuated inversion
recovery; fMRI: functional Magnetic Resonance Imaging; FSS: Fatigue Severity Scale; GEE: Generalized Estimating Equations; GLM: General Linear Modelling; GPA: Granulomatosis
with Poliangiitis; HC: Healthy Control; HIV: Human Immunodeficiency Virus; ICA: Independent Component Analysis; IFN-α: Interferon—α; MANCOVA: Multivariate Analysis of
Variance; MFI: Multidimensional Fatigue Inventory; MRS: Magnetic Resonance Spectroscopy; MS: Multiple Sclerosis; MTR: Magnetization Transfer Ratio; NA: Not applicable; PASAT:
Paced Auditory Serial Attention Task; PBC: Primary Biliary Cirrhosis; pCASL: pseudo-Continuous Arterial Spin Labelling; PF-SF36: Physical Functioning scale from the 36-item Short
Form Health Survey; PPS: Postpoliomyelitis syndrome; PRESS: Point Resolved Spectroscopy; qMT: quantitative Magnetization Transfer; ROC: Receiver Operating Characteristic; SF-36:
Short Form 36; sMRI: structural Magnetic Resonance Imaging; STAI: State and Trait Anxiety Inventory; TNF: Tumor Necrosis Factor; ToL: Tower of London; VAS-f: Visual Analogue
Scale—fatigue; VWMT: Verbal Working Memory Task. a Mean plus range; b Median plus IQR.
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3.3. Quality Assessment
All 26 studies were assessed for quality (Table 2). Nineteen studies [39,40,91,93,95–98,100,101,103,
106–108,110–114] were of high quality, as they met all the quality criteria. Four studies [99,102,104,109]
were of very good quality and two of good quality [92,94]. One study [105] was judged to be of fair
quality, because it had incomplete inclusion/exclusion criteria, lacked details of the imaging protocol,
statistical assessment and did not have an analysis of the limitations of the study.
Table 2. Quality assessment of included studies.
Reference Year Pathology Design
Scoring Criteria for Quality Assessment Score
1 2 3 4 5 6 7 8 9 10 (%)
[93] 2015 AS
Cross-sectional
Y Y Y Y Y Y
N
Y Y N 100Longitudinal Y
[97] 2014 AS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[98] 2015 Cancer Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[99] 2014 Cancer Longitudinal Y Y Y Y Y N Y Y Y Y 90
[100] 2013 Cancer
Cross-sectional
Y Y Y Y Y Y Y Y Y Y 100Longitudinal
[101] 2004 PBC Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[96] 2014 GPA Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[102] 2013 GPA Cross-sectional Y Y Y Y Y N Y Y Y Y 90
[103] 2013 Gulf War Illness Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[104] 2016 Hepatitis C Longitudinal Y Y Y Y Y Y N Y Y Y 90
[105] 2010 HIV Longitudinal Y N N Y Y N Y N Y N 50
[95] 2014 PPS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[92] 1994 PPS Cross-sectional Y Y Y N Y Y N Y Y Y 80
[39] 2016 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[40] 2016 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[106] 2015 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[107] 2015 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[108] 2014 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[109] 2011 CFS Cross-sectional Y Y Y Y Y Y Y Y Y N 90
[110] 2008 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[91] 2008 CFS Longitudinal Y Y Y Y Y Y Y Y Y Y 100
[111] 2006 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[112] 2005 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[94] 2004 CFS Cross-sectional Y Y N Y Y Y Y Y Y N 80
[113] 2004 CFS Cross-sectional Y Y Y Y Y Y Y Y Y Y 100
[114] 1995 CFS Longitudinal Y Y Y Y Y Y Y Y Y Y 100
Assessment criteria questions: (1) Does the study have a clearly defined research objective? (2) Does the study
adequately describe the inclusion criteria? (3) Does the study adequately describe the exclusion criteria? (4) Does the
study report on the population parameters/demographics? (5) Does the study report details on assessment of pain?
(6) Does the study provide details of imaging protocol? (7) Does the study provide a proper control group? (8) Does
the study apply proper statistical analysis? Correction for multiple comparisons? (9) Does the study adequately
report on the strength of the results (e.g., ways of calculating effect sizes, reporting of confidence intervals/standard
deviation)? (10) Do the authors report on the limitations of their study? Y = yes, N = no, Y/N = applies partially;
AS: Ankylosing Spondylitis; CFS: Chronic Fatigue Syndrome; GPA; Granulomatosis with Poliangiitis; HIV: Human
Immunodeficiency Virus; PBC: Primary Biliary Cirrhosis; PPS: Pospoliomyelitis Syndrome.
3.4. Synthesis of Results
Brain correlates of fatigue were extracted for each of the studies, and they are summarized in
Table 3.
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Table 3. Results of brain indicators of fatigue for each study.
Reference Pathology Summary of Key Neuroimaging Findings Related to Fatigue Quality Score(/10)
[93] AS
Negative correlation between fatigue reduction after anti TNF-α
therapy and cortical thickness of the insula, primary sensory
cortex/inferior parietal sulcus and superior temporal polysensory
areas.
100
[97] AS
Negative correlation between fatigue scores and amount of GM in
areas of the dorsal and ventral attention networks, the
somatosensory cortices, and the caudate nucleus.
Positive correlation between fatigue scores and GM within the
executive control network and putamen.
100
[98] Cancer Positive correlation between fatigue and ToL task BOLDactivation across groups in the dorsomedial prefrontal cortex. 100
[99] Cancer Prediction of post-treatment fatigue severity by pre-treatmentspatial variance in executive network activation. 90
[100] Cancer No significant findings. 100
[101] PBC
Positive correlation between fatigue score and blood manganese
and copper concentrations.
Significant reduction in globus pallidus/WM and globus
pallidus/PU MTR indices in the high fatigue group compared
with the low fatigue group, in stage I–II patients.
100
[96] GPA
↑ activation in the right thalamus, left paracentral lobule, left
medial frontal gyrus and right medial globus pallidus among
GPA cases compared with GPA controls.
100
[102] GPA ↑ structural integrity in fornix and cingulum among GPA cases. 90
[103] Gulf War Illness Positive correlation of fatigue, pain, and ↑ axial diffusivity withthe right inferior fronto-occipital fasciculus. 100
[104] Hepatitis C Correlations bilaterally between shifts in kf and T2f within theventral striatum and the subsequent development of fatigue. 90
[105] HIV ↓ levels of the cellular energy marker total creatine in the basalganglia within fatigued participants. 50
[95] PPS No significant findings. 100
[92] PPS
Small discrete or multiple punctate areas of hyperintense signal
(HS) in the reticular formation, putamen, medial leminiscus or
WM tracts imaged in 55% of the subjects reporting ↑ fatigue and
none in those reporting ↓ fatigue.
80
[39] CFS
Negative correlation between fatigue ratings and connectivity
between left parahippocampal gyrus connectivity and left
postcentral gyrus and left supra-marginal gyrus. Positive
correlation between fatigue and connectivity of anterior cingulate
cortex withthe posterior cingulate cortex, left thalamus, and
left hippocampus.
100
[40] CFS
Negative correlation between fatigue and fC between salience
network and posterior cingulate cortex. Negative correlation
between fatigue and fC between resting state network and
anterior midcingulate cortex.
100
[106] CFS Positive correlation between fatigue and connectivity betweenposterior cingulate cortex and dorsal anterior cingulate cortex. 100
[107] CFS No significant findings. 100
[108] CFS Negative correlation between fatigue and activation in the rightglobus pallidus. 100
[109] CFS Negative correlation between fatigue duration and WM volumein the midbrain. 90
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Table 3. Cont.
Reference Pathology Summary of Key Neuroimaging Findings Related to Fatigue Quality Score(/10)
[110] CFS
During provocation of fatigue, ↑ activation in the occipito-parietal
cortex, posterior cingulate gyrus and parahippocampal gyrus,
and ↓ activation in dorsolateral and dorsomedial prefrontal
cortices in CFS compared to controls.
100
[91] CFS Significant ↑ in GM volume, localized in the lateral prefrontalcortex in CFS cases, with CBT. 100
[111] CFS
During 1-back condition, ↑ activation in medial prefrontal regions,
including the anterior cingulate gyrus, in CFS cases compared to
control subjects.
On more challenging conditions, ↓ activation in dorsolateral
prefrontal and parietal cortices in CFS cases.
On the 2- and 3-back conditions, significant activation of a large
cluster in the right inferior/medial temporal cortex in CFS cases.
100
[112] CFS
Positive correlation between fatigue and BOLD signal change in
the left superior parietal region, bilateral supplemental and
premotor regions.
100
[94] CFS Negative correlation between fatigue and right dorsolateralprefrontal-cortex. 80
[113] CFS No significant findings 100
[114] CFS White-matter lesions in a minority from all groups. 100
AS: Ankylosing Spondylitis; BOLD: Blood Oxygen Level Dependent; CBT: Cognitive Behavioural Therapy; CFS:
Chronic Fatigue Syndrome; FC: functional connectivity; GM: Grey Matter; GPA; Granulomatosis with Poliangiitis;
HIV: Human Immunodeficiency Virus; MFI: Multidimensional Fatigue Inventory; MTR: Magnetization Transfer
Ratio; PBC: Primary Biliary Cirrhosis; PPS: Pospoliomyelitis Syndrome; TOL: Tower of London; WM: White Matter.
From a total of 26 studies, seven of the studies adopted a longitudinal approach, while the
remaining ones were cross-sectional (Figure 2).
Figure 2. Distribution of longitudinal and cross-sectional studies per disease.
Next, the results are explained:
(a) Disease type
Neural correlates of fatigue in ankylosing spondylitis were mainly found in the parietal lobe,
specifically in the inferior parietal sulcus [93] and postcentral gyrus [93,97], and the basal ganglia
(caudate nucleus and putamen [97]). Other regions such as superior temporal polysensory area and
insula were correlated with fatigue reduction after anti TNF-α therapy. Fatigue scores [97] were
negatively correlated with GM volume in the dorsal and ventral attention networks, and positively
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correlated in the executive control network. In the case of granulomatosis with polyangiitis (GPA) [96],
higher activation during a fatigue task in the medial frontal gyrus, paracentral lobule, globus pallidus
and thalamus was found, while Basu et al. suggested fornix and cingulum play an important role in
GPA-related fatigue [102]. With regard to chronic fatigue syndrome (CFS), results between studies were
heterogeneous. Most of the significant correlates of fatigue were found in the frontal lobe (dorsolateral
prefrontal cortex [94,110], dorsomedial prefrontal cortex [110], medial prefrontal cortex [111], lateral
prefrontal cortex [91], medial superior frontal gyrus [106], and bilateral supplemental and premotor
region [112]) and the limbic system (parahippocampal gyrus [39,110], anterior cingulate [39,40,106,111],
posterior cingulate [39,40,110], and thalamus and hippocampus [39]). Other areas related to fatigue
were found in the parietal lobe (supramarginal gyrus and postcentral gyrus [39], and superior parietal
region [112]), midbrain [109] and globus pallidus [108]. Cope et al. found white matter lesions
in a minority of all groups [114], while Zeineh et al. and De Lange et al. reported no significant
findings [107,113]. Studies in other diseases reported varying results. Regarding cancer, dorsomedial
prefrontal cortex [98] and executive network [99] were found to be related with fatigue. In [100]
no significant findings were reported. Other correlates with cognitive fatigue were found in globus
pallidus in the case of cirrhosis [101], ventral striatum in Hepatitis C [104] and inferior fronto-occipital
fasciculus in Gulf War Illness [103], whereas in postpoliomyelitis (PPS), putamen, reticular formation
and medial leminiscus was related with fatigue [92], while Trojan et al. did not find significant
results [95]. Finally, basal ganglia was related to fatigue in HIV patients [105], although the quality of
this study was judged to be only fair.
(b) Neuroimaging technique
FMRI was employed in nine of the studies: cancer [98,99], GPA [96] and CFS [106,108,110–113].
DTI was carried out in 5 of the studies: AS [97], cancer [98], GPA [102], Gulf War Illness [103]
and CFS [107]. Functional connectivity was assessed in CFS [39,40,106]. MRS was employed in
cancer [98,100], cirrhosis [101] and HIV [105]. Other techniques such as qMT were used in Hepatitis
C [104] and MTR in cirrhosis [101]. The different fatigue-induced approaches during the fMRI included
the Tower of London task [98], Paired Associates Memory Task [98], verbal working memory task [99],
Paced Auditory Serial Attention Test (PASAT) [96,112], gambling [108], n-Back task [111] and a motor
and visual imagery task [113].
4. Discussion
4.1. Summary of Evidence
In the present article, we have systematically reviewed the available MRI studies in chronic
diseases where fatigue is a common burden. In the case of ankylosing spondylitis (AS), a form of
arthritis, fatigue is considered as a significant symptom [21,115]. This symptom is so prevalent in AS
that it has been suggested to be considered as an independent domain from other symptoms related
to the disease, such as pain or impairment [116]. This review compiled two AS studies reporting
fatigue-related structures [93,97]. Some of these structures, such as insula, dorsal and ventral attention
network and the executive control network are related to cognitive functions, while other structures
such as the primary sensory cortex, inferior parietal sulcus and superior temporal polysensory area
are involved in sensory experience. Cancer-related fatigue is the most prevalent and debilitating
symptom reported by patients [117]. Approximately 90% of patients treated with radiation and 80%
of patients treated with chemotherapy suffer from fatigue [118]. In this review, we gathered three
studies regarding cancer-related fatigue, although just two of them, relating to breast cancer, stated
significant findings. Blesch et al. reported that 99% of breast cancer patients experienced some level of
fatigue [119]. Dorsomedial prefrontal cortex and the executive network were found to be related to
fatigue, being both structures involved in cognitive functions. With regard to primary biliary cirrhosis,
a long-term liver disease, long term fatigue affects approximately 68–85% of the patients [7,120],
considered as the worst or one of the worst symptoms in around half of them [120]. Only one paper
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studying fatigue correlates in PBC accomplished the inclusion criteria of this review. This paper
reported the globus pallidus structure, associated with the regulation of voluntary movement, to be
related with fatigue. Granulomatosis with Poliangiitis (GPA) is a rare multisystem autoimmune
disorder of undetermined etiology. Although fatigue prevalence in GPA has not been reported, studies
within other rheumatic disorders exhibited rates between 60% and 90% [121–123]. In this review, two
studies regarding the GPA-related fatigue were presented. Basu et al. reported several brain regions
related to fatigue, such as thalamus, paracentral lobule and the medial global pallidus [96]. These areas
are mainly linked to sensory and motor coordination. Same authors found the fornix and cingulum,
both part of the limbic system, involved in the experience of this symptom [102]. Gulf War Illness is
a chronic and multisymptomatic illness that affects military veterans of the Gulf War. This disorder is
characterized by a wide range of symptoms, including significant fatigue, muscle pain and cognitive
issues among others [124]. The experience of permanent fatigue is frequently described by Gulf War
veterans [125–128]. Kelsall et al. reported that up to 66% of Gulf War patients suffer from mild to severe
fatigue [125]. Furthermore, between 1.6 and 5.1% of these patients met the chronic fatigue syndrome
criteria [126,129,130]. This review found only one study related to fatigue in Gulf War Illness [103].
The study found a correlation between fatigue and axial diffusivity in the inferior fronto-occipital
fasciculus. This brain structure is related to the integration of auditory and visual association. Hepatitis
C is caused by the hepatitis virus which, in turn, leads to the swollenness of the liver. a study found
fatigue to be present in two thirds of patients with chronic Hepatitis C [131]. Another study reported
that 53% of Hepatitis C patients suffer from fatigue. In 17% of these patients, fatigue was so severe
that it led to activity impairment [132]. The only study reported in this review about Hepatitis C
found the development of fatigue related to the ventral striatum [104], which mainly intercedes in
reward cognition, reinforcement and motivation. HIV is a virus which attacks the immune system,
which is the body’s natural defence against infections and diseases. Prevalence of fatigue in HIV
has varying rates according to the stage of the disease, ranging from no fatigue in the early stage
of the disease, to almost 80% in AIDS patients [8,133–138]. Just one study regarding HIV met the
inclusion criteria of this review and hence, was assessed [105]. Here, basal ganglia was associated with
fatigue. Patients who suffered from paralytic poliomyelitis can develop postpoliomyelitis syndrome
(PPS) years or even decades later. PPS is a disorder where patients suffer from a generalized fatigue,
generally reported as the most burdensome symptom of the disease [139]. Approximately 66% to
89% of PPS patients suffer from high levels of fatigue [140–142]. Two studies regarding PPS-related
fatigue were assessed. However, just one of them found significant findings. Reticular formation,
putamen and medial leminiscus were indicated as possible correlates of fatigue. These structures are
thought to be involved in several functions, such as behavioural arousal and consciousness, regulation
of movements and somatosensation from the skin and joints. Chronic fatigue syndrome is a complex
disorder whose most common symptom is extreme fatigue. In the UK, the prevalence of CFS has been
rated between 11% [143] and 15% [144] per 100,000 people. This disorder has been widely studied and
it has been the most reported illness in this article. a total of 13 CFS studies related to fatigue were
gathered. The majority of them found areas related to executive and cognitive functions, memory
and perception.
The brain structures found to be related to fatigue in the studies compared were highly
heterogeneous, not only between diseases, but also for different studies within the same diseases.
The most common structures were the frontal lobe, parietal lobe, limbic system and basal ganglia.
These structures are associated with attention, memory, planning, integration of sensory information
and learning.
Longitudinal studies, as opposed to cross-sectional studies, allow tracking of the same subjects
over time, removing confounders such as cultural differences, age, etc. Therefore, they offer more
precise and reliable indicators. In addition, they can give information about accumulative processes.
What is more, they may allow the prediction of future changes in fatigue by assessing baseline factors.
In spite of this, just seven out of 26 studies were longitudinal [91,93,99,100,104,105,114], and six
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involved an interventional procedure. Within these six interventional studies, one was low quality and
only employed MRS [105], one only recorded structural images and did not include a proper control
group [104], and another only recorded structural images [93]. The fact that longitudinal designs allow
follow-up of the patient during an intervention procedure, offering more precise indicators of the
population changes, and their potential as prediction models, make them the best strategy to follow
in the search of neural correlates of fatigue. Therefore, longitudinal neuroimaging studies following
a fatigue treatment would be of inestimable worth in the study of this symptom.
sMRI, fMRI, DTI and FC studies identified significant neural correlates of fatigue, demonstrating
that they are very useful techniques in the search for the processes responsible for fatigue within
chronic illnesses. The integration of these techniques may be helpful in the search of biomarkers,
rather than using them individually [145]. However, none of the studies in this review integrated
all of them. sMRI, fMRI and DTI were integrated in [98] and sMRI, fMRI and FC in [106],
both of them with no follow-up. Other studies have combined two of the techniques; sMRI
and fMRI [96,108,111–113], sMRI and DTI [97,102,107], or sMRI and FC [40,72]. Integration of
modalities is an attractive strategy to follow in the development of a comprehensive map of the
pathophysiological brain networks of fatigue. This multimodal approach has demonstrated a more
comprehensive understanding of brain changes in disorders such as amyotrophic lateral sclerosis [146],
schizophrenia [147–157], bipolar disorder [158–161], characterization of tumours [162], traumatic brain
injury [163], Parkinson’s disease [164], psychosis [165,166], Alzheimer’s disease [167,168] and mild
cognitive impairment [169–171]. Therefore, it should be expected that the integration of techniques
may help to elucidate further brain mechanisms of fatigue.
4.2. Limitations
This systematic review aimed to perform a comprehensive search of all studies employing MR
techniques in the investigation of neural indicators of fatigue. Although a great number of references
were gathered, it is still conceivable that other related papers have been overlooked. Furthermore,
the inclusion criteria set a lower limit of studies with more than 10 subjects. This limit was based on
fMRI which tend to have lower sample sizes than sMRI studies. This may mean that lower power, and
therefore lower quality, sMRI studies may have been included than would otherwise be the case with
a larger sample size threshold. We acknowledge the diversity in the way that fatigue was measured in
the studies examined. Furthermore, studies employing fMRI make use of different tasks to induce
fatigue. These facts increase the risk of bias and will inevitably contribute to a disparity in results.
Finally, we acknowledge that the study of brain correlates by means of neuroimaging is insufficient to
offer a comprehensive explanation of the mechanisms underlying fatigue. The integration of other
types of biomarkers, such as biochemical ones, may provide further understanding of the phenomenon.
5. Conclusions
We have found that studies searching for neural indicators of fatigue within chronic diseases are of
variable design and quality. Regarding the fatigue indicators, we found that there are not well-defined
neural correlates of fatigue in any chronic diseases so far. Different designs and methodologies for the
same illness offered different results. From this, we conclude that there are no common correlates of
fatigue across chronic diseases. According to the employed design, it seems that the best strategy in
the search of neural correlates of fatigue would be to integrate different neuroimaging techniques in
a longitudinal study, with a fatigue alleviating intervention. Such an approach could be a great asset to
unravel the neural mechanisms of this burdensome and neglected symptom.
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Abbreviations
ALS Amyotrophic Lateral Sclerosis
AS Ankylosing Spondylitis
BOLD Blood Oxygen Level Dependent
CFS Chronic Fatigue Syndrome
CNS Central Nervous System
CT Computed Tomography
DTI Diffusion Tensor Imaging
FC Functional Connectivity
FM Fibromyalgia
fMRI Functional Magnetic Resonance Imaging
GM Grey Matter
GPA Granulomatosis with Polyangiitis
HIV Human Immunodeficiency Virus
MR Magnetic Resonance
MRI Magnetic Resonance Imaging
MRS Magnetic Resonance Spectroscopy
MS Multiple Sclerosis
PASAT Paced Auditory Serial Attention Test
PET Positron Emission Tomography
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
qMT Quantitative Magnetization Transfer
RA Rheumatoid Arthritis
SLE Systemic Lupus Erythematosus
sMRI Structural Magnetic Resonance Imaging
SR Systematic Review
VBM Voxel Based Morphometry
WM White Matter
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